Skip to main content
Clinical Trials/NCT04865354
NCT04865354CompletedNot Applicable

Clinical Comparison of Two Daily Disposable Contact Lenses

Alcon Research8 sites in 1 country170 target enrollmentStarted: May 17, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
170
Locations
8
Primary Endpoint
Least Squares Mean Distance VA (logMAR) With Study Lenses

Study Overview

Brief Summary

The purpose of this study is to compare the clinical performance of PRECISION1™ contact lenses to Clariti® 1 day contact lenses.

Detailed Description

Subjects will be expected to attend 3 study visits and wear the study lenses daily for at least 10 hours per day. On the day prior to Visits 2 and 3, subjects will be expected to wear the study lenses for at least 16 hours. The total duration of subject participation will be up to 22 days.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Successful wearer of spherical soft contact lenses with at least 3 months wearing experience, with a minimum wearing time of 5 days per week and 10 hours per day.
  • •Possess spectacles and willing to wear habitual spectacles for vision correction when study lenses are not worn, as needed.
  • •Willing to wear contact lenses for at least 16 hours on one of the days (day prior to each week 1 visit).
  • •Other protocol-specified inclusion criteria may apply.

Exclusion Criteria

  • •Habitual PRECISION1, Clariti 1-Day, and DAILIES TOTAL1 contact lens wearers.
  • •Any monovision and multifocal lens wearers.
  • •Other protocol-specified exclusion criteria may apply.

Arms & Interventions

PRECISION1, then Clariti 1-Day

Other

Verofilcon A contact lenses worn first, with somofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) for 8 days in a daily disposable modality.

Intervention: Somofilcon A contact lenses (Device)

PRECISION1, then Clariti 1-Day

Other

Verofilcon A contact lenses worn first, with somofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) for 8 days in a daily disposable modality.

Intervention: Verofilcon A contact lenses (Device)

Clariti 1-Day, then PRECISION1

Other

Somofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) for 8 days in a daily disposable modality.

Intervention: Verofilcon A contact lenses (Device)

Clariti 1-Day, then PRECISION1

Other

Somofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) for 8 days in a daily disposable modality.

Intervention: Somofilcon A contact lenses (Device)

Outcomes

Primary Outcomes

Least Squares Mean Distance VA (logMAR) With Study Lenses

Time Frame: Day 8, each study lens type

Distance visual acuity (VA) was assessed with study lenses in place. VA was collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal visual acuity), with a negative value denoting better than 20/20 visual acuity.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (8)

Loading locations...

Similar Trials